<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-045214</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Description of immunogens of Chlamydia pneumoniae recognized by serum of individuals with peripheral artery disease</dc:title>
<dc:description xml:lang="en">Background and objective: The relationship between antibodies to C. pneumoniae and presence of the bacteria was studied in individuals with peripheral arterial disease. Patients and method: An observational analytical, case-control study was performed in 118 patients (68 cases, 50 controls) to investigate immunoglobulin (Ig) G and A against C. pneumoniae in serum, using Western-blot (commercial and no commercial methods), ELISA and MIF; DNA of the bacteria in vascular tissue biopsy specimens was studied by polymerase chain reaction. Results: Using commercial Western-blot, significant presence of IgG anti-39 kDa and anti-54 kDa was found in cases and was related to MIF results and C. pneumoniae DNA findings; IgA anti-LPS, anti-92 kDa and anti-Hsp60 kDa were also found and related to DNA presence. Using no commercial Western-blot, significant presence of 128.8 and 9.2 kDa bands for IgG was detected in cases and associated with DNA presence; 70.8, 58.9, 47.9, 47.5, 18.4, 12.1, 10.6, 8.1, and 7.6 kDa bands for IgG were found in cases; and DNA was present when 54.6 and 1.1 kDa bands for IgG and 79.4, 50.1, and 18.4 kDa bands for IgA were also detected. Conclusions: Using Western-blot, a greater serologic response was found against certain proteins of the bacteria in individuals with peripheral arterial disease. This may reflect an initial stage with presence of DNA and specific IgG. Subsequently, even in absence of the bacteria, an immunomediated disease may develop with presence of IgA and IgG</dc:description>
<dc:creator>Ros, Eduardo</dc:creator>
<dc:creator>Palanca, Matilde</dc:creator>
<dc:creator>Ana Camacho, Ana</dc:creator>
<dc:creator>Sorlózano, Antonio</dc:creator>
<dc:creator>Gutiérrez, José</dc:creator>
<dc:creator>Linares, José</dc:creator>
<dc:creator>Soto, María José</dc:creator>
<dc:creator>Maroto, Carmen</dc:creator>
<dc:creator>Luna, Juan de Dios</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento y objetivo: Se estudian, en sujetos con enfermedad arterial periférica, los tipos de anticuerpos frente a Chlamydia pneumoniae y su relación con la presencia de la bacteria. Pacientes y método: Se ha realizado un estudio en 68 casos y 50 controles en los que se investigaron en suero las inmunoglobulinas (Ig) G y A frente a C. pneumoniae mediante Western-blot (comercial y no comercial), enzimoinmunoanálisis y microinmunofluorescencia (MIF), así como el ADN de la bacteria en biopsia de tejido vascular mediante reacción en cadena de la polimerasa. Resultados: Mediante Western-blot comercial se encontró, en los casos, una presencia significativa de IgG anti-39 kDa y anti-54 kDa, que se relacionaron con los resultados obtenidos mediante MIF y con la presencia de ADN de C. pneumoniae; así como de IgA antilipopolisacárido, anti-92 kDa y anti-Hsp60 kDa, que se relacionaron con la presencia de ADN. Mediante Western-blot no comercial destacó la presencia significativa, en los casos, de las bandas de 128,8 y 9,2 kDa para la IgG, que se asoció con la existencia de ADN; también se detectaron en los casos bandas de IgG de 70,8, 58,9, 47,9, 47,5, 18,4, 12,1, 10,6, 8,1 y 7,6 kDa; asimismo se detectó ADN cuando se observaron las bandas de 54,6 y 1,1 kDa de IgG, y las bandas de 79,4, 50,1 y 18,4 kDa de IgA. Conclusiones: En los sujetos con enfermedad arterial periférica se encontró una respuesta serológica, mediante Western-blot, más importante frente a determinadas proteínas de la bacteria. Esto podría reflejar una fase inicial con presencia de ADN e IgG específica. Posteriormente, aun en ausencia de la bacteria, podría existir una enfermedad inmunomediada con presencia de IgA e IgG</dc:description>
<dc:source>Med. clín (Ed. impr.);126(19): 721-727, mayo 2006. ilus, tab</dc:source>
<dc:identifier>ibc-045214</dc:identifier>
<dc:title xml:lang="es">Descripción de inmunógenos de Chlamydia pneumoniae reconocidos por el suero de sujetos con enfermedad arterial periférica</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d22153^s22002</dc:subject>
<dc:subject>^d23966^s22038</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22206^s22002</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d22202^s22002</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:subject>^d28224^s22074</dc:subject>
<dc:subject>^d1163^s22046</dc:subject>
<dc:subject>^d30191^s22052</dc:subject>
<dc:subject>^d30191^s22001</dc:subject>
<dc:type>article</dc:type>
<dc:date>200605</dc:date>
</metadata>
</record>
</ibecs-document>
